The value of the serum cytokine-to-immune ratio model in predicting the progression-free survival after interventional therapy for hepatocellular carcinoma

Jun Zhou, Bo Zhang, Jing Niu · 2026

Read The value of the serum cytokine-to-immune ratio model in predicting the progression-free survival after interventional therapy for hepatocellular carcinoma by Jun Zhou, Bo Zhang, Jing Niu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13312616.txt.

Description

Jun Zhou, Bo Zhang, and Jing Niu build in 2026 a forecast tool for liver cancer patients treated with two local therapies. The treatments block the tumor's blood supply with chemotherapy and burn it with radio waves. The question is who stays free of growth afterward, so follow-up drugs can be aimed well.

Their chart rests on three blood measures: two signal proteins and the ratio of two immune cell types. Records of 138 patients were split into building and checking sets. Tumor count and cancer stage joined the blood marks as firm forecast factors. Rival learning models were also trained, and a tool that explains each model's calls helped pick the winner.

Catalog record

CREATORJun Zhou, Bo Zhang, Jing Niu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13312616

Browse the full library · About the Tower of Babel